• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Dermatology

Various factors impact quality of life in patients with chronic pruritus

byAdam WhittingtonandAngela Wang
March 30, 2014
in Dermatology
Reading Time: 2 mins read
Various factors impact quality of life in patients with chronic pruritus
Share on FacebookShare on Twitter

Image: NCBI 

1. Demographic characteristics, personality, etiology, and pruritus parameters (such as duration, frequency, severity, and location) significantly affected quality of life in patients with chronic pruritus. 

Evidence Rating Level: 2 (Good)          

Study Rundown: Chronic pruritus (CP) has a considerable prevalence and has been demonstrated to have a similar impact on quality of life (QoL) as chronic pain. Although various factors have been attributed to CP, such as mood, sleep, and concentration disturbances, there have been no direct measures of differences in parameters on QoL. Thus, these authors performed a cross-sectional study examining the effects of demographics, personality, and etiology on QoL in patients with CP. Results indicated that age, race, marital status, presence of disease, and personality significantly affected QoL in patients with CP. Additionally, other factors that mediated the impact of CP on QoL included the severity, frequency, duration, and location of pruritus. BMI, income, employment status, education level, sex, and region of residence were found to be non-significant variables. Strengths of this study include the regionally diverse population and the variety of factors tested in the questionnaire. However, due to its recruitment from the Veterans Hospital Patient Database, the results may be more suggestive for an older, Caucasian male population.

Click to read the study in JAMA Dermatology

Relevant Reading: Effect of the pruritus on the quality of life: a preliminary study

RELATED REPORTS

Difelikefalin reduces pruritus in adults with notalgia paresthetica

In-Depth [cross-sectional study]: A total of 6000 patients from the Veterans Hospital Patient Database were contacted to participate in this QoL survey. Of those, 405 participants who reported CP were administered the complete 300+ question survey. The ItchyQoL instrument was used to measure the degree that CP affected QoL and the NEO 5-factor inventory was used to determine personality. Analysis of relationships between variable and QoL were completed using both t testing and Χ2 testing. Results indicated that older age and married status were negatively correlated with decreasing QoL (P = 0.04 and 0.06 respectively) while African American race, presence of disease, extroversion, neuroticism, pruritus afflicting the upper extremities, and increased severity, frequency, and duration of CP were positively correlated with decreasing QoL. Factors such as sex, education, and socioeconomic status were not significant.

More from this author: Video-based behavioral intervention benefits clinical skin examinations, Biofilm-producing staphylococci occlude eccrine sweat ducts in atopic dermatitis, Initial primary invasive or in situ melanoma increases risk of subsequent invasive melanoma

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: pruritus
Previous Post

Decreased breast cancer recurrence and mortality following post-mastectomy radiotherapy

Next Post

Colchicine safe and effective for recurrent pericarditis [CORP-2 trial]

RelatedReports

Topical pimecrolimus use for atopic dermatitis not linked to malignancy
Chronic Disease

Difelikefalin reduces pruritus in adults with notalgia paresthetica

February 16, 2023
Next Post
Colchicine safe and effective for recurrent pericarditis [CORP-2 trial]

Colchicine safe and effective for recurrent pericarditis [CORP-2 trial]

Adolescents’ muscle strength associated with lower cardiometabolic risk

Adolescents’ muscle strength associated with lower cardiometabolic risk

Transcatheter aortic valve replacement provides only minor benefit to quality of life

2 Minute Medicine Rewind March 23 – March 30, 2014

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.